Related Experiment Video

Updated: Mar 16, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

1.5K

BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy

J K Nozynski1, D Konecka-Mrowka1, M Zakliczynski2

  • 1Department of Histopathology, Silesian Centre for Heart Diseases, Zabrze, Upper Silesia, Poland.

Transplantation Proceedings
|August 7, 2016
PubMed

Insights

Breast cancer gene 1 (BRCA1) expression is altered in idiopathic dilated cardiomyopathy (IDCM). IDCM adverse remodeling leads to more intense, nonuniform BRCA1 staining in heart cells, impacting DNA repair and apoptosis.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer gene 1 (BRCA1) plays a role in DNA repair and apoptosis.
  • BRCA1 is implicated in adverse remodeling and ischemic cardiomyopathy.
  • The role of BRCA1 in idiopathic dilated cardiomyopathy (IDCM) requires investigation.

Purpose of the Study:

  • To investigate the role of BRCA1 in idiopathic dilated cardiomyopathy (IDCM).

Main Methods:

  • Myocardial samples from 10 IDCM patients and 10 control donors were analyzed.
  • BRCA1 expression was detected using immunohistochemistry.
  • Staining intensity was semiquantitatively assessed in cardiocytes, small vessels, and interstitial cells.

Main Results:

  • All IDCM cases showed positive, nonuniform BRCA1 expression.
  • Hypertrophied cardiocytes in IDCM exhibited intense BRCA1 staining; other cardiomyopathic cells showed weak, mosaic staining.
  • BRCA1 staining intensity was significantly higher in IDCM cardiocytes compared to controls.

Conclusions:

  • Idiopathic dilated cardiomyopathy (IDCM) is associated with more intense but nonuniform BRCA1 expression.
  • This altered expression pattern reflects IDCM biology, with varying DNA repair and anti-apoptotic activity in myocytes.
  • BRCA1's role in IDCM may involve differential effects on hypertrophied versus other cardiomyopathic cells.
Abstract

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
731
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
750
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K